Yes, yes, Chris, I’d like – maybe I’d like to explain a little history here. I don’t know if I’ve done that on a conference call. But you know we joined forces with Air Products about two and a half years ago. At that time, they had indicated a very strong interest into being the major supplier to the personal care cosmetics field. Why? High margins, growth market. And they were looking at getting very strong presence in that space through acquisition and through possible investments in technology for a variety of reasons. That – by the way, through the acquisition route, they would have had the ability to have worldwide marketing and sales access immediately. The acquired company who have that capability would have had formulation capability. For a variety of reasons that acquisition has not happened. And so we are all kind of in a little bit of a wait mode, when is that going to happen. And as a result of waiting and not seeing that come, Air Products has decided to start to build its own internal capabilities in marketing and sales both in Europe and the U.S., North America. And so they have been doing that, putting a small team together of people in Europe and in the U.S. that call on the S D Lotters [ph] and the Procter and Gambles and the Avons and the L'Oreals, and a very small formulation team. So, it’s been slow go, not because of poor intent, but just because they have been frustrated in their attempts to try to get instant access to the market through acquisition. So, it’s a kind of a home-grown approach. And so right now we are in roughly I believe it somewhere between eight to 10 products of the L'Oreal family of products. Our ingredients are in the Veeshe [ph], the Keels [ph], the Land Comb [ph], and the L'Oreal product lines. And so we have additives in those materials – in those products. So, the key of course, is to start to expand the market with other customers. And so, it’s about a two to three year process before you – by the time you make a call, you have samples that start to get evaluating, they go through safety and toxicology testing, and then they go through what’s called the coding process, c-o-d-i-n-g, coding process, and then it’s got to be scaled. So, there is a lag time on that. It’s – fortunately it’s faster than drug development, but it’s certainly a couple of year. And so that’s a process we are in right now. So, there is a small team in Europe, there is a small in the U.S. calling on customers. There is a small formulation team. We still support Air Products with R&D, with new product development. And our hope is that now that we have this small team in place we can start to build some momentum.